Organogenesis Holdings Inc. (ORGO) Ownership
ORGO ownership summary
as of October 17, 2026- Institutions
- 51.7% of shares outstanding
- Insiders
- 44.56% of shares outstanding
- Shares outstanding
- 128.7M
- Float
- 61.1M shares available to trade
- Short interest
- 18.34% 15.0M shares short
- Days to cover
- 22.84 short interest up 6.2% vs prior month
- Institutions 51.70%
- Insiders 44.56%
- Other investors 3.74%
ORGO top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Morgan Stanley - Brokerage Accounts | 9.11% | 11.7M | $11.7M | +104,814 (+0.9%) | June 30, 2026 |
| 2 | Soleus Capital Management, L.P. | 7.88% | 10.1M | $10.1M | +55,000 (+0.5%) | June 30, 2026 |
| 3 | BlackRock Inc | 5.63% | 7.2M | $7.2M | +2.3M (+48.0%) | June 30, 2026 |
| 4 | Assenagon Asset Management SA | 3.06% | 3.9M | $3.9M | +2.0M (+100.0%) | June 30, 2026 |
| 5 | Dimensional Fund Advisors, Inc. | 2.37% | 3.1M | $3.1M | +159,291 (+5.5%) | June 30, 2026 |
| 6 | AQR Capital Management LLC | 2.34% | 3.0M | $3.0M | +2.1M (+241.6%) | June 30, 2026 |
| 7 | Vanguard Capital Management, LLC | 2.26% | 2.9M | $2.9M | +5,103 (+0.2%) | June 30, 2026 |
| 8 | D. E. Shaw & Co LP | 2.24% | 2.9M | $2.9M | +590,339 (+25.7%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 1.50% | 1.9M | $1.9M | +151,590 (+8.5%) | June 30, 2026 |
| 10 | Deutsche Bank AG | 1.33% | 1.7M | $1.7M | +505 (+0.0%) | June 30, 2026 |
| 11 | Vanguard Portfolio Management, LLC | 1.25% | 1.6M | $1.6M | +158,637 (+10.9%) | June 30, 2026 |
| 12 | Acadian Asset Management LLC | 1.20% | 1.5M | $1.5M | −31,559 (−2.0%) | June 30, 2026 |
| 13 | State Street Corp | 1.18% | 1.5M | $1.5M | −5,153 (−0.3%) | June 30, 2026 |
| 14 | Renaissance Technologies Corp | 0.79% | 1.0M | $1.0M | −51,425 (−4.8%) | June 30, 2026 |
| 15 | Charles Schwab Investment Management Inc | 0.70% | 905K | $905,024 | +25,192 (+2.9%) | June 30, 2026 |
| 16 | The Goldman Sachs Group Inc | 0.69% | 887K | $887,399 | +367,049 (+70.5%) | June 30, 2026 |
| 17 | Citadel Advisors Llc | 0.67% | 868K | $867,929 | +323,694 (+59.5%) | June 30, 2026 |
| 18 | FLAX POND CAPITAL, LLC | 0.65% | 843K | $842,682 | +422,591 (+100.6%) | June 30, 2026 |
| 19 | SG Americas Securities, LLC | 0.60% | 773K | $772,737 | −18,029 (−2.3%) | June 30, 2026 |
| 20 | Jacobs Levy Equity Management, Inc. | 0.54% | 692K | $692,197 | +692,197 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 16 holders added 9.5M shares and 4 cut 106K.
ORGO top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Xtrackers S&P 500 Swap ETF 1C | 2.51% | 3.2M | $3.2M | −23,782 (−0.7%) | December 31, 2025 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 1.55% | 2.0M | $2.0M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 1.41% | 1.8M | $1.8M | −20,928 (−1.1%) | September 30, 2026 |
| 4 | Invesco Consumer Discr S&P US SelSec ETF | 1.20% | 1.5M | $1.5M | +1.5M (0.0%) | December 31, 2025 |
| 5 | Fidelity Small Cap Index | 0.59% | 754K | $754,323 | −929 (−0.1%) | July 31, 2026 |
| 6 | iShares Russell 2000 Value ETF | 0.49% | 632K | $632,065 | +958 (+0.2%) | September 30, 2026 |
| 7 | Vanguard Explorer Inv | 0.38% | 492K | $492,497 | — | June 30, 2026 |
| 8 | Schwab US Small-Cap ETF™ | 0.31% | 399K | $399,426 | +270 (+0.1%) | September 30, 2026 |
| 9 | Vanguard Russell 2000 ETF | 0.31% | 396K | $396,242 | +7,920 (+2.0%) | August 31, 2026 |
| 10 | DFA US Targeted Value I | 0.28% | 356K | $356,422 | — | August 31, 2026 |
| 11 | Schwab Small-Cap Equity | 0.27% | 342K | $341,648 | — | June 30, 2026 |
| 12 | Vanguard Strategic Equity Inv | 0.26% | 334K | $334,062 | — | June 30, 2026 |
| 13 | Fidelity Extended Market Index | 0.22% | 289K | $289,086 | −97,437 (−25.2%) | August 31, 2026 |
| 14 | DFA US Small Cap Value I | 0.22% | 285K | $284,690 | — | August 31, 2026 |
| 15 | Dimensional US Small Cap Value ETF | 0.21% | 268K | $267,878 | — | September 24, 2026 |
| 16 | DFA US Micro Cap I | 0.19% | 239K | $239,079 | — | August 31, 2026 |
| 17 | Dimensional US Targeted Value ETF | 0.17% | 221K | $221,009 | — | September 30, 2026 |
| 18 | Vanguard Health Care ETF | 0.17% | 221K | $220,788 | +29,552 (+15.5%) | August 31, 2026 |
| 19 | iShares Micro-Cap ETF | 0.17% | 219K | $218,523 | −1,507 (−0.7%) | September 30, 2026 |
| 20 | Dimensional US Core Equity 2 ETF | 0.16% | 205K | $204,782 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ORGO insider transactions
latest 13| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-09 | Arthur S Leibowitz | Buy | $2.68 | 5,000 | $13,400 |
| 2026-03-09 | Michael Joseph Driscoll | Buy | $2.67 | 10,000 | $26,700 |
| 2025-12-16 | Glenn H Nussdorf | Sell | $5.14 | 200,000 | $1.0M |
| 2025-11-26 | Glenn H Nussdorf | Sell | $5.29 | 187,957 | $994,293 |
| 2025-11-25 | Glenn H Nussdorf | Sell | $5.30 | 12,043 | $63,828 |
| 2025-11-24 | Glenn H Nussdorf | Sell | $5.34 | 100,000 | $534,000 |
| 2025-06-10 | Glenn H Nussdorf | Sell | $3.56 | 18,620 | $66,287 |
| 2025-06-09 | Glenn H Nussdorf | Sell | $3.50 | 4,156 | $14,546 |
| 2025-06-06 | Lori Freedman | Buy | $2.99 | 9,022 | $26,976 |
| 2025-06-05 | Lori Freedman | Buy | $2.91 | 142,379 | $414,323 |
| 2025-06-04 | Lori Freedman | Buy | $2.82 | 100,863 | $284,434 |
| 2025-05-15 | Glenn H Nussdorf | Buy | $2.99 | 107,494 | $321,407 |
| 2025-05-14 | Glenn H Nussdorf | Buy | $3.09 | 251,001 | $775,593 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ORGO shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ORGO
Institutional investors own 51.7% of Organogenesis's shares and insiders 44.56%. The largest holder is Morgan Stanley - Brokerage Accounts with 9.11% of the shares (11.7M), as of June 30, 2026. Among the top 20 institutions, 16 added shares and 4 reduced their stake in the latest filings. Short interest is 18.34% of the float, or 22.84 days of average trading volume. The share count rose 1,569.3% since 2016.
Related: ORGO analyst forecast, ORGO key metrics. See the ORGO stock overview for the latest quote and news.
ORGO ownership FAQ
Who owns the most Organogenesis stock?
The largest shareholders of Organogenesis are Morgan Stanley - Brokerage Accounts (9.11%), Soleus Capital Management, L.P. (7.88%), BlackRock Inc (5.63%), Assenagon Asset Management SA (3.06%), Dimensional Fund Advisors, Inc. (2.37%).
What percentage of Organogenesis is owned by institutions?
Institutions hold 51.7% of Organogenesis's shares outstanding; insiders hold 44.56%.
Which funds own Organogenesis?
The largest fund holders of Organogenesis are Xtrackers S&P 500 Swap ETF 1C (2.51%), Vanguard MStar Total Stk Mkt Idx Invest (1.55%), iShares Russell 2000 ETF (1.41%), Invesco Consumer Discr S&P US SelSec ETF (1.20%), Fidelity Small Cap Index (0.59%).
What is Organogenesis's short interest?
15.0M shares of Organogenesis were sold short, 18.34% of the float; at the average daily volume it would take 22.84 days to cover.
Are insiders buying or selling Organogenesis?
Of the latest 13 reported insider transactions in Organogenesis (since May 14, 2025), 7 were purchases and 6 were sales.
How many shares of Organogenesis are outstanding?
Organogenesis has 128.7M shares outstanding, of which 61.1M are in the public float.